Synthesis of tetrasubstituted bicyclo[3.2.1]octenes as potential inhibitors of influenza virus sialidase

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 4, 1999, Pages 605-610

  Jones, Paul S ^a   Smith, Paul W ^a   Hardy, George W ^a   Howes, Peter D ^a   Upton, Richard J ^a   Bethell, Richard C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDO BICYCLO[3.2.1]OCTENOL; AMIDE; BICYCLO[3.2.1]OCTANE DERIVATIVE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS SIALIDASE; ZANAMIVIR;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; RACEMIC MIXTURE;

BICYCLO COMPOUNDS, HETEROCYCLIC; ENZYME INHIBITORS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; NEURAMINIDASE;

INFLUENZA VIRUS; INFLUENZAVIRUS A; INFLUENZAVIRUS B;

EID: 0033593857     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00032-3     Document Type: Article

References (19)

1. 1. Whittington, A.R.; Bethell, R.C. Exp. Opin. Ther. Patents. 1995, 5, 793.
2. 2. Hayden, F.G; Treanor, J.J; Betts, R.F; Lobo, M; Esinhart, J.; Hussey, E. J. Amer. Med. Assoc. 1996, 275, 295.
3. 3. Sollis, S.L.; Smith, P.W.; Howes, P.D.; Cherry, P.C.; Bethell, R.C. Bioorg. Med. Chem. Lett. 1996, 6, 1805.
4. 4. Smith, P.W.; Sollis, S.L.; Howes, P.D.; Cherry, P.C.; Cobley, K.N.; Taylor, H.; Whittington, A.R.; Scicinski, J.; Bethell, R.C.; Taylor, N.R.; Skarzynski, T.; Cleasby, A.; Singh, O.; Wonacott, A.; Varghese, J.; Colman, P. Bioorg. Med. Chem. Lett. 1996, 6, 2931.
5. 5. Smith, P.W.; Whittington, A.R.; Sollis, S.L.; Howes, P.D.; Taylor, N.R. Bioorg. Med. Chem. Lett. 1997, 7, 2239.
6. 6. Smith, P.W.; Robinson, J.Ed.; Evans, D.N.; Sollis, S.L.; Howes, P.D.; Trivedi, N.; Bethell, R.C. Bioorg. Med. Chem. Lett. 1999, 9, 601-604.
7. 7. Chand, P.; Babu, Y.S.; Bantia, S.; Chu, N.; Cole, L.B.; Kotian, P.L.; Laver, W.G.; Montgomery, J.A.; Pathak, V.P.; Petty, S.L.; Shrout, D.P.; Walsh, D.A.; Walsh, G.M. J. Med. Chem. 1997, 40, 4030.
8. 8. Williams, M.; Bischofberger, N.; Swaminathan S.; Kim, C.U. Bioorg. Med. Chem. Lett. 1995, 5, 2251.
9. 9. Bischofberger, N.W.; Kim, C.U.; Lew, W.; Liu, H.; Williams, M.A. Preparation of selective inhibitors of viral or bacterial neuraminidases. PCT Int. Appl., WO 9626933. CAN 125:300503.
10. 10. Kim, C.U.; Lew, W.; Williams, M.A.; Zhang, L.; Liu, H.; Swaminathan, S.; Bischofberger, N.; Chen, M.S.; Tai, C.Y.; Mendel, D.B.; Laver, W.G.; Stevens, R.C. J. Am. Chem. Soc. 1997, 119, 681.
11. 11. Kim, C.U.; Lew, W.; Williams, M.A.; Wu, H.; Zhang, L.;Chen, X.; Escarpe, P.A.; Mendel, D.B.; Laver, W.G.; Stevens, R.C. J. Med. Chem. 1998, 41,2451.
12. 12. Filippini, M.; Faure, R. ;Rodriguez, J. J. Org. Chem. 1995, 60, 6872.
13. 13. Prepared by the method of Tietze, L.F.; Meier, H.; Voss, E. Synthesis, 1988, 274
14. 14. Taskinen, E.; Hellman, J. Magn. Reson. Chem. 1994, 353.
15. 15. Mueller, L.G.; Lawton, R.G. J. Org. Chem., 1979, 44, 4741.
16. 3).
17. 17. Saksena, A.K.; Mangiaracina, P. Tetrahedron Lett. 1983, 24, 273.
18. 18. Ninomiya, K.; Shioiri, T.; Yamada, S. Tetrahedron 1974, 30, 2151.
19. 50 value quoted is the concentration of inhibitor required to reduce the enzymic activity in this preparation by 50%.